期刊文献+

泰安市结核病防治院2011年痰培养阳性肺结核就诊患者的耐药状况分析 被引量:12

Analysis of Mycobacterium tuberculosis drug-resistance situation of sputum culture positive patients visiting Tai'an Tuberculosis Prevention and Treatment Hospital in 2011
暂未订购
导出
摘要 目的分析泰安市结核病防治院痰培养阳性肺结核就诊患者的耐药状况。方法就2011年1月至12月在泰安市结核病防治院就诊的233例痰培养阳性肺结核患者对S、Km、INH、RFP、EMB和PAS等6种抗结核药物的药敏情况及耐药类型进行分析。初治组患者171例,复治组患者62例,结果比较采用χ2检验,P<0.05为差异有统计学意义。结果233例痰培养阳性肺结核患者的耐药率为52.36%(122/233),其中初治痰培养阳性患者耐药率为51.46%(88/171);复治痰培养阳性患者耐药率为54.84%(34/62)。痰培养阳性肺结核患者对一线抗结核药物耐药率较高,INH耐药率最高(30.04%,70/233),其次是S(24.46%,57/233)、EMB(23.18%,54/233)和RFP(16.74%,39/233)。耐药类型中,主要是多耐药结核病(50.00%,61/122),其次是单耐药结核病(28.69%,35/122)和MDR-TB(21.31%,26/122)。233例患者的MDR-TB耐药率为11.16%(26/233),复治患者中MDR-TB的耐药率(19.35%,12/62)高于初治组(8.19%,14/171),差异有统计学意义(χ2=5.724,P<0.05);用过抗结核药的初治患者中MDR-TB的耐药率(23.08%,6/26)高于未用抗结核药的初治患者(5.52%,8/145),差异有统计学意义(χ2=6.699,P<0.05)。结论泰安市结核病防治院就诊的痰培养阳性的肺结核患者总体耐药率及INH、S、EMB和RFP的耐药率较高;复治患者和曾用过抗结核药的初治患者更容易发生MDR-TB。 Objective To analyze the Mycobacterdum tuberculosis drug-resistance situation of sputum cuhur, positive patients visiting Tai'an TB Prevention and Treatment Hospital. Methods From January 2011 to Decem ber 2011, a total of 233 sputum culture positive patients visited Tai'an TB Prevention and Treatment Hospital, weanalyzed their drug susceptibility situation for 6 kinds of anti-TB drugs, namely S, Km, INH, RFP, EMB and PAS and their resistance pattern. According to the treatment history, patients were divided into new patients grout (171 cases) and retreatment group (62 cases). Chisquare test was used to analyze if the difference is statistically significant (P〈0.05). Results The overall drugresistant rate of 233 sputum culture patients was 52.36%, (122/233), with 51.46%(88/171) in new patients and 54.84G (34/62) in retreatment patients. Sputum cultur, positive patients had high drug susceptibility rate to first line drugs, with the highest of INH (30.04G, 70/233/ followed by S (24.46G ,57/233), EMB (23.18% ,54/2331 and RFP(16.74% ,39/233). In terms of resistance pat tern, the majority was multidrug resistant TB (50.00% 61/122), followed by singledrug resistant TB (28.69% 35/122/ and multi drug resistant (MDR) TB (21.31%, 26/122). The overall MDRTB rate was 11.16%(26/233), with 19.35G(12/62) in new patients and 8.19%(14/171) in new patients, the difference between two, groups is statistically significant(χ2= 5. 724, P〈C0.05). The MDR-TB rate (23.08 %, 6/26 ) in patients ever usec anti-TB drugs was higher than those never taken anti TB drugs before (5.52G ,8/145), and the difference is statis tically significant(χ2=6. 699,P〈0.05). Conclusion The overall drugresistance rate of Mycobacterium tuberculosi and INH, S, EMB, RFP drugresistance rates are high in sputum culturepositive patients visiting Tai’an TB Pre vention and Treatment Hospital, and the retreatment and new patients who had taken anti-TB drugs before are mor likely to develop MDR TB.
出处 《中国防痨杂志》 CAS 2012年第11期736-739,共4页 Chinese Journal of Antituberculosis
基金 泰安市科技发展计划(20113091)
关键词 结核 分枝杆菌 抗药性 细菌 泰安市 Tuberculosis, pulmonary Mycobacterium Drug resistance, bacterial Taian city
  • 相关文献

参考文献10

二级参考文献47

  • 1谢强,孙卫红,翁丽珍,邹盛华.BACTEC MGIT-960临床应用与结果分析[J].临床肺科杂志,2004,9(4):350-352. 被引量:6
  • 2谭卫国,杨应周,罗道泉,吴清芳,张玉华,罗育希.深圳市结核分枝杆菌耐药监测疫情趋势分析[J].中华检验医学杂志,2005,28(8):805-806. 被引量:18
  • 3端木宏谨.耐药结核病的流行和监测[J].中华结核和呼吸杂志,2006,29(8):509-511. 被引量:38
  • 4柳正卫,何海波,缪梓萍,李群.984株结核分枝杆菌耐药情况分析[J].中国防痨杂志,2007,29(2):167-170. 被引量:33
  • 5World Health Organization/International Union Against Tuberculosis and Lung Disease. Guideline for surveillance of drug resistance in tuberculosis [S]. Ceneva: WHO, 1997.
  • 6WHO/IUATLD Global Project on Anti2tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world. Third repor[J]. WHO/HTM/TB/2004. 343. Geneva: WHO, 2004.
  • 7王甦民,刘宇红,姜广路,刘洋,付育红,端木宏谨.世界卫生组织中国结核病耐药监测的结果评价[J].中华检验医学杂志,2007,30(8):863-866. 被引量:48
  • 8Ann M.Loeffler,MD.耐药结核病:临床医生使用指南.第2版.中国疾病预防控制中心结核病防治临床中心,中华医学会结核病学分会,世界卫生组织结核病研究培训合作中心翻译、出版,2007,1-11.
  • 9Herrera L, Valverde A, Saiz P, et al. Molecular characterization of isoniazid-resistantMycobacterium tuberculosisclinieal strains isolated in the Philippines. Int J Antimierob Agents ,2004,23:572-576.
  • 10Johnson R, Streicher EM, Louw GE, et al. Drug resistance in Mycobacterium tuberculosis. Curr Issues Mol Biol,2006 ,8 :97-111.

共引文献346

同被引文献82

引证文献12

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部